|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Technical Data
| Formula | C21H18ClFN6O2 |
|||
| Molecular Weight | 439.85 | CAS No. | 1453848-26-4 | |
| Solubility (25°C)* | In vitro | DMSO | 88 mg/mL (200.06 mM) | |
| Ethanol | 88 mg/mL (200.06 mM) | |||
| Water | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |
||||
Preparing Stock Solutions
Biological Activity
| Description | Ravoxertinib (GDC-0994) is a potent, orally available and highly selective ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1. | ||||
|---|---|---|---|---|---|
| Targets |
|
||||
| In vitro | GDC-0994 potently inhibits phospho-p90RSK in tumor cells. [1] |
||||
| In vivo | GDC-0994 (p.o.) results in significant single-agent activity in multiple in vivo cancer models, including KRAS-mutant and BRAF-mutant human xenograft tumors in mice. [1] In vivo, GDC-0994 (p.o.) inhibits both ERK phosphorylation and activation of ERK-mediated signal transduction pathways, and subsequently prevents ERK-dependent tumor cell proliferation and survival. [2] |
Protocol (from reference)
| Animal Study: |
|
|---|
References
Customer Product Validation
-
Data from [Data independently produced by , , Blood, 2018, 131(18):2047-2059]
-
Data from [Data independently produced by , , Biochim Biophys Acta, 2015, 1852(12):2671-7]
-
Data from [Data independently produced by , , Biochem Biophys Res Commun, 2017, 486(4):1062-1068]
-
Data from [Data independently produced by , , Cell Immunol, 2017, 314:63-72]
Selleck's Ravoxertinib (GDC-0994) has been cited by 67 publications
| DUSP22 Ameliorates Endothelial-to-Mesenchymal Transition in HUVECs through Smad2/3 and MAPK Signaling Pathways [ Cardiovasc Ther, 2024, 2024:5583961] | PubMed: 38495810 |
| Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis [ EMBO J, 2023, e114153.] | PubMed: 37382276 |
| Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis [ Pharmacol Res, 2023, 197:106955] | PubMed: 37820855 |
| High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer [ Mol Cancer Ther, 2023, 22(2):227-239] | PubMed: 36442478 |
| ERK1/2-Dependent Phosphorylation of GABAB1(S867/T872), Controlled by CaMKIIβ, Is Required for GABAB Receptor Degradation under Physiological and Pathological Conditions [ Int J Mol Sci, 2023, 24(17)13436] | PubMed: 37686242 |
| ERK1/2-Dependent Phosphorylation of GABAB1-S867/T872), Controlled by CaMKIIβ, Is Required for GABAB Receptor Degradation under Physiological and Pathological Conditions [ Int J Mol Sci, 2023, 24(17)13436] | PubMed: 37686242 |
| Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway [ Cancers (Basel), 2023, 15(3)809] | PubMed: 36765767 |
| Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway [ Cancers (Basel), 2023, 15(3)809] | PubMed: 36765767 |
| A Chemical Proteomics Approach to Discover Regulators of Innate Immune Signaling [ Viruses, 2023, 15(5)1112] | PubMed: 37243198 |
| Synergism of Carbamoylated Erythropoietin and Insulin-like Growth Factor-1 in Immediate Early Gene Expression [ Life (Basel), 2023, 13(9)1826] | PubMed: 37763230 |
RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.
NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.